English  |  正體中文  |  简体中文  |  總筆數 :2826201  
造訪人次 :  31832766    線上人數 :  1499
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"pei jer chen"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 621-645 / 883 (共36頁)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-07-03T03:33:37Z Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection Lin P.-H.; Wong W.-I.; Wang Y.-L.; Hsieh M.-P.; Lu C.-W.; Liang C.-Y.; Jui S.-H.; Wu F.-Y.; PEI-JER CHEN; Yang H.-C.
臺大學術典藏 2021-07-03T03:33:36Z Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection Yang H.-C.; Tsou H.-H.; Pei S.-N.; Chang C.-S.; Chen J.-H.; Yao M.; Lin S.-J.; Lin J.; Yuan Q.; Xia N.; Liu T.-W.; PEI-JER CHEN; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology Group
臺大學術典藏 2021-07-03T03:33:36Z Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:35Z Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients Hu H.-H.;Liu J.;Chang C.-L.;Jen C.-L.;Lee M.-H.;Lu S.-N.;Wang L.-Y.;Quan Y.;Xia N.-S.;Chen C.-J.;Pei-Jer Chen;Yang H.-I.; Hu H.-H.; Liu J.; Chang C.-L.; Jen C.-L.; Lee M.-H.; Lu S.-N.; Wang L.-Y.; Quan Y.; Xia N.-S.; Chen C.-J.; PEI-JER CHEN; Yang H.-I.
臺大學術典藏 2021-07-03T03:33:35Z Taiwan consensus statement on the management of chronic hepatitis B Chien R.-N.;Kao J.-H.;Peng C.-Y.;Chen C.-H.;Liu C.-J.;Huang Y.-H.;Hu T.-H.;Yang H.-I.;Lu S.-N.;Ni Y.-H.;Chuang W.-L.;Lee C.-M.;Wu J.-C.;Pei-Jer Chen;Liaw Y.-F.; Chien R.-N.; Kao J.-H.; Peng C.-Y.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Hu T.-H.; Yang H.-I.; Lu S.-N.; Ni Y.-H.; Chuang W.-L.; Lee C.-M.; Wu J.-C.; PEI-JER CHEN; Liaw Y.-F.
臺大學術典藏 2021-07-03T03:33:35Z Evaluation of SH-SAW Biosensor in Whole Blood Kano K.; Huang Y.-Q.; Kogai T.; Huang Y.-T.; Yatsuda H.; PEI-JER CHEN; Liu S.-H.
臺大學術典藏 2021-07-03T03:33:35Z Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; Hong C.-M.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:34Z Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection Su T.-H.;Liu C.-J.;Tseng T.-C.;Chou S.-W.;Liu C.-H.;Yang H.-C.;Wu S.-J.;Pei-Jer Chen;Chen D.-S.;Chen C.-L.;Kao J.-H.; Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:34Z Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions Yu M.-L.;Hung C.-H.;Huang Y.-H.;Peng C.-Y.;Lin C.-Y.;Cheng P.-N.;Chien R.-N.;Hsu S.-J.;Liu C.-H.;Huang C.-F.;Su C.-W.;Huang J.-F.;Liu C.-J.;Kao J.-H.;Chuang W.-L.;Pei-Jer Chen;Chen D.-S.; Yu M.-L.; Hung C.-H.; Huang Y.-H.; Peng C.-Y.; Lin C.-Y.; Cheng P.-N.; Chien R.-N.; Hsu S.-J.; Liu C.-H.; Huang C.-F.; Su C.-W.; Huang J.-F.; Liu C.-J.; Kao J.-H.; Chuang W.-L.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:34Z Profile and value of FIB-4 in patients with dual chronic hepatitis C and B Liu C.-J.;Tseng T.-C.;Yang W.-T.;Su T.-H.;Yang H.-C.;Liu C.-H.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Liu C.-J.; Tseng T.-C.; Yang W.-T.; Su T.-H.; Yang H.-C.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:34Z Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development Hu J.;Lin Y.-Y.;Pei-Jer Chen;Watashi K.;Wakita T.; Hu J.; Lin Y.-Y.; PEI-JER CHEN; Watashi K.; Wakita T.
臺大學術典藏 2021-07-03T03:33:33Z Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma Su T.-H.;Liu C.-J.;Tseng T.-C.;Chou S.-W.;Liu C.-H.;Yang H.-C.;Wu S.-J.;Pei-Jer Chen;Chen D.-S.;Chen C.-L.;Kao J.-H.; Su T.-H.; Liu C.-J.; Tseng T.-C.; Chou S.-W.; Liu C.-H.; Yang H.-C.; Wu S.-J.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:33Z Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region Li C.-L.;Li C.-Y.;Lin Y.-Y.;Ho M.-C.;Chen D.-S.;Pei-Jer Chen;Yeh S.-H.; Li C.-L.; Li C.-Y.; Lin Y.-Y.; Ho M.-C.; Chen D.-S.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏 2021-07-03T03:33:33Z Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase Wang Y.-H.;Chuang Y.-H.;Wu C.-F.;Jan M.-C.;Wu W.-J.;Lin C.-L.;Liu C.-J.;Yang Y.-C.;Pei-Jer Chen;Lin S.-M.;Tsai M.-H.;Huang Y.-W.;Yu M.-W.; Wang Y.-H.; Chuang Y.-H.; Wu C.-F.; Jan M.-C.; Wu W.-J.; Lin C.-L.; Liu C.-J.; Yang Y.-C.; PEI-JER CHEN; Lin S.-M.; Tsai M.-H.; Huang Y.-W.; Yu M.-W.
臺大學術典藏 2021-07-03T03:33:32Z Lymphocyte Antigen 6 Complex, Locus C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in Mice Wu L.-L.;Peng W.-H.;Wu H.-L.;Miaw S.-C.;Yeh S.-H.;Yang H.-C.;Liao P.-H.;Lin J.-S.;Chen Y.-R.;Hong Y.-T.;Wang H.-Y.;Pei-Jer Chen;Chen D.-S.; Wu L.-L.; Peng W.-H.; Wu H.-L.; Miaw S.-C.; Yeh S.-H.; Yang H.-C.; Liao P.-H.; Lin J.-S.; Chen Y.-R.; Hong Y.-T.; Wang H.-Y.; PEI-JER CHEN; Chen D.-S.
臺大學術典藏 2021-07-03T03:33:32Z Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection Liu C.-H.;Su T.-H.;Liu C.-J.;Hong C.-M.;Yang H.-C.;Tseng T.-C.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Liu C.-H.; Su T.-H.; Liu C.-J.; Hong C.-M.; Yang H.-C.; Tseng T.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:32Z Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus–Associated Hepatocellular Carcinoma Li Y.-T.;Wu H.-L.;Kao J.-H.;Cheng H.-R.;Ho M.-C.;Wang C.-C.;Pei-Jer Chen;Chen D.-S.;Liu C.-J.; Li Y.-T.; Wu H.-L.; Kao J.-H.; Cheng H.-R.; Ho M.-C.; Wang C.-C.; PEI-JER CHEN; Chen D.-S.; Liu C.-J.
臺大學術典藏 2021-07-03T03:33:32Z Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection Liu J.;Hu H.-H.;Chang C.-L.;Jen C.-L.;Lee M.-H.;Lu S.-N.;Wang L.-Y.;Yuan Q.;Xia N.-S.;Sugiyama M.;Nishida N.;Mizokami M.;Chen C.-J.;Pei-Jer Chen;Yang H.-I.; Liu J.; Hu H.-H.; Chang C.-L.; Jen C.-L.; Lee M.-H.; Lu S.-N.; Wang L.-Y.; Yuan Q.; Xia N.-S.; Sugiyama M.; Nishida N.; Mizokami M.; Chen C.-J.; PEI-JER CHEN; Yang H.-I.
臺大學術典藏 2021-07-03T03:33:31Z Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg-Positive Children With a Normal Alanine Aminotransferase Level Chen H.-S.;Wu J.-F.;Su T.-H.;Chen H.-L.;Hsu H.-Y.;Xia N.-S.;Pei-Jer Chen;Chang M.-H.; Chen H.-S.; Wu J.-F.; Su T.-H.; Chen H.-L.; Hsu H.-Y.; Xia N.-S.; PEI-JER CHEN; Chang M.-H.
臺大學術典藏 2021-07-03T03:33:31Z NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging Su T.-H.;Liao S.-H.;Hong C.-M.;Liu C.-J.;Tseng T.-C.;Liu C.-H.;Yang H.-C.;Pei-Jer Chen;Chen D.-S.;Chen C.-L.;Adhoute X.;Bourli?Re M.;Kao J.-H.; Su T.-H.; Liao S.-H.; Hong C.-M.; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourli?re M.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:31Z Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis Liu C.-H.;Shih Y.-L.;Yang S.-S.;Lin C.-L.;Fang Y.-J.;Cheng P.-N.;Chen C.-Y.;Peng C.-Y.;Hsieh T.-Y.;Chiu Y.-C.;Su T.-H.;Liu C.-J.;Yang H.-C.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.
臺大學術典藏 2021-07-03T03:33:30Z Antiviral treatment for hepatitis B in infancy: Still an issue for debate Chen H.-L.;Ni Y.-H.;Pei-Jer Chen;Chang M.-H.; Chen H.-L.; Ni Y.-H.; PEI-JER CHEN; Chang M.-H.
臺大學術典藏 2021-07-03T03:33:30Z Specific diacylglycerols generated by hepatic lipogenesis stimulate the oncogenic androgen receptor activity in male hepatocytes Cheng Y.-W.;Chen K.-W.;Kuo H.-C.;Kuo C.-H.;Lin W.-H.;Pei-Jer Chen;Yeh S.-H.; Cheng Y.-W.; Chen K.-W.; Kuo H.-C.; Kuo C.-H.; Lin W.-H.; PEI-JER CHEN; Yeh S.-H.
臺大學術典藏 2021-07-03T03:33:29Z Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection Tsou H.-H.; Yang H.-C.; Hsiao C.-F.; Hsiung C.A.; Liu T.-W.; Chuang M.-H.; Wu H.-Y.; Hsu Y.-T.; Tsui C.-W.; PEI-JER CHEN; Cheng A.-L.; Hsu C.; Taiwan Cooperative Oncology Group
臺大學術典藏 2021-07-03T03:33:29Z High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load Tseng T.-C.;Liu C.-J.;Hsu C.-Y.;Hong C.-M.;Su T.-H.;Yang W.-T.;Chen C.-L.;Yang H.-C.;Huang Y.-T.;Fang-Tzu Kuo S.;Liu C.-H.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H.

顯示項目 621-645 / 883 (共36頁)
<< < 20 21 22 23 24 25 26 27 28 29 > >>
每頁顯示[10|25|50]項目